| Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology WJ Gradishar, BO Anderson, J Abraham, R Aft, D Agnese, KH Allison, ... Journal of the National Comprehensive Cancer Network 18 (4), 452-478, 2020 | 814 | 2020 |
| Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology WJ Gradishar, MS Moran, J Abraham, R Aft, D Agnese, KH Allison, ... Journal of the National Comprehensive Cancer Network 20 (6), 691-722, 2022 | 599 | 2022 |
| NCCN guidelines® insights: Breast cancer, version 4.2021: Featured updates to the NCCN guidelines WJ Gradishar, MS Moran, J Abraham, R Aft, D Agnese, KH Allison, ... Journal of the National Comprehensive Cancer Network 19 (5), 484-493, 2021 | 271 | 2021 |
| NCCN Guidelines® Insights: breast cancer, version 4.2023: featured updates to the NCCN guidelines WJ Gradishar, MS Moran, J Abraham, V Abramson, R Aft, D Agnese, ... Journal of the National Comprehensive Cancer Network 21 (6), 594-608, 2023 | 155 | 2023 |
| Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population WI Gonsalves, T Tashi, J Krishnamurthy, T Davies, S Ortman, R Thota, ... Journal of palliative medicine 14 (11), 1231-1235, 2011 | 102 | 2011 |
| Retrospective analysis of treatment patterns and effectiveness of palbociclib and subsequent regimens in metastatic breast cancer J Xi, A Oza, S Thomas, F Ademuyiwa, K Weilbaecher, R Suresh, R Bose, ... Journal of the National Comprehensive Cancer Network 17 (2), 141-147, 2019 | 73 | 2019 |
| The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios S Singhal, E Vickrey, J Krishnamurthy, V Singh, S Allen, J Mehta Blood, The Journal of the American Society of Hematology 114 (1), 38-39, 2009 | 63 | 2009 |
| Optimizing the CD34+ cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation J Mehta, J Mehta, O Frankfurt, J Altman, A Evens, M Tallman, L Gordon, ... Leukemia & lymphoma 50 (9), 1434-1441, 2009 | 41 | 2009 |
| Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: a Veterans' Affairs Central Cancer Registry (VACCR) database analysis WI Gonsalves, S Kanuri, T Tashi, I Aldoss, A Sama, I Al‐Howaidi, A Ganta, ... Journal of Surgical Oncology 104 (6), 667-671, 2011 | 40 | 2011 |
| Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients M Akhtari, VR Bhatt, PK Tandra, J Krishnamurthy, H Horstman, ... Cancer Biology & Therapy 14 (12), 1077-1088, 2013 | 36 | 2013 |
| Risk factors, therapy and survival outcomes of small cell and large cell neuroendocrine carcinoma of urinary bladder VR Bhatt, FR Loberiza Jr, P Tandra, J Krishnamurthy, R Shrestha, J Wang Rare tumors 6 (1), 10-14, 2014 | 33 | 2014 |
| Salivary duct carcinoma responding to trastuzumab‐based therapy: case report and review of the literature J Krishnamurthy, DM Krishnamurty, JJ Baker, W Zhen, D Lydiatt, AK Ganti Head & neck 35 (12), E372-E375, 2013 | 33 | 2013 |
| Identification and management of lymphedema in patients with breast cancer P Tandra, A Kallam, J Krishnamurthy Journal of oncology practice 15 (5), 255-262, 2019 | 32 | 2019 |
| Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths P Tandra, J Krishnamurthy, VR Bhatt, K Newman, JO Armitage, M Akhtari Mediterranean journal of hematology and infectious diseases 5 (1), 2013 | 29 | 2013 |
| NCCN clinical practice guidelines in oncology (NCCN guidelines®) WJ Gradishar, BO Anderson, J Abraham, R Aft, D Agnese, KH Allison, ... Journal of the National Comprehensive Cancer Network 18 (4), 2020 | 22 | 2020 |
| Genomic complexity predicts resistance to endocrine therapy and CDK4/6 inhibition in hormone receptor–positive (HR+)/HER2-negative metastatic breast cancer AA Davis, J Luo, T Zheng, C Dai, X Dong, L Tan, R Suresh, ... Clinical Cancer Research 29 (9), 1719-1729, 2023 | 21 | 2023 |
| Targeting the Sanctuary Site: Options when Breast Cancer Metastasizes to the Brain. M Krishnan, J Krishnamurthy, N Shonka Oncology (08909091) 33 (8), 2019 | 14 | 2019 |
| Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma? V Singh, J Krishnamurthy, S Duffey, R Meagher, M Villa, J Monreal, ... Bone marrow transplantation 43 (4), 301-305, 2009 | 14 | 2009 |
| Undifferentiated embryonal sarcoma of liver A Kallam, J Krishnamurthy, J Kozel, N Shonka Rare Tumors 7 (4), 130-132, 2015 | 12 | 2015 |
| Clinicopathologic characteristics and management trends of cutaneous invasive and in situ melanoma in older patients: a retrospective analysis of the National … VR Bhatt, R Shrestha, J Krishnamurthy, K Mosalpuria, FR Loberiza Jr, ... Therapeutic Advances in Medical Oncology 7 (1), 4-11, 2015 | 10 | 2015 |
Vijaya Raj BhattUniversity of Nebraska Medical Center在 unmc.edu 的电子邮件经过验证
